Open access
Sep 2026
Comparative effects of enavogliflozin versus dapagliflozin on adipokines in patients with type 2 diabetes mellitus: a pooled analysis of two randomized controlled trials
Although SGLT2 inhibitor–induced amelioration of adipokines is known to confer cardiometabolic benefits, it remains unclear whether individual SGLT2 inhibitors differ in their effects on adipokine regulation. In this study, we compared the effects of enavogliflozin and dapagliflozin on adipokine levels in patient...
Y. Lyu, Kyung-Soo Kim, H. Lee et al.
· Cardiovascular Diabetology · 0 citations